Cabazitaxel Accord - direct healthcare professional communication (DHPC)

cabazitaxel

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Cabazitaxel Accord 20 mg/mL concentrate for solution for infusion: Risk of medication errors and mix-up with Jevtana (60 mg/1.5 mL) concentrate and solvent for solution for infusion

Key facts

• Medicine name:
  Cabazitaxel Accord
• Active substance:
  cabazitaxel
• Therapeutic area (MeSH):
  Prostatic Neoplasms, Castration-Resistant
• Procedure number:
  EMEA/H/C/005178
• DHPC type:
  Medication error
• Human ATC codes:
  L01CD